Corcept Therapeutics CORT Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's total current liabilities?
- Corcept Therapeutics (CORT) reported total current liabilities of $149.19M in Q1 2026.
- How has Corcept Therapeutics's total current liabilities changed year-over-year?
- Corcept Therapeutics's total current liabilities increased by 4.3% year-over-year, from $143.07M to $149.19M.
- What is the long-term trend for Corcept Therapeutics's total current liabilities?
- Over 5 years (2020 to 2025), Corcept Therapeutics's total current liabilities has grown at a 28.5% compound annual growth rate (CAGR), from $47.49M to $166.09M.
- What does total current liabilities mean?
- The total amount of debt and obligations due within one year.
- How do you interpret total current liabilities?
- A high or increasing value relative to current assets may signal liquidity pressure, while a lower value suggests a stronger short-term financial position.
- How does total current liabilities compare across companies?
- Standard financial metric; peers are compared based on their current ratio (current assets divided by current liabilities).